SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Teva Pharmaceuticals
TEVA 20.49+2.3%3:59 PM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RonBerk who wrote (331)11/1/2022 10:18:23 PM
From: Lance Bredvold1 Recommendation

Recommended By
RonBerk

  Read Replies (1) of 340
 
I watched something similar for RPM with asbestos liability suits. For many years the stock languished with spikes every time hopes it was over arrived with some settlement. As the years went by, suits became just ridiculous as lawyers advertised their ability to win for people who might of might not have a real complaint. I always felt RPM acted responsibly but at some point had to stop the payouts. As I understand it (and it may be apocryphal) they eventually funded a large terminal fund and spun it out with a division they had low hopes for (perhaps the dryvit company which they'd acquired for their asbestos derived product) and all suits went to that company allowing RPM to resume it's growth strategy unhampered.

But I warn you that my understanding would be modified a lot by anyone who had really studied the situation and final outcome. Plus I have no real understanding of where TEVA et al are relative to settling all initial complaints--many of which are legitimate.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News